-
Improving Kidney Exchange Program Effectiveness and Equity by Using Allele and Eplet HLA Compatibility Technologies
Sep 9, 2025, 16:22 PM -
Gatekeepers of Science: Evolving Publishing Policies in the Age of AI
Sep 9, 2025, 16:22 PM -
Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in France: A Use Case in Rare Diseases
Sep 9, 2025, 16:22 PM -
Health Technology Assessment (HTA) Systems and Risk Identification Strategies: A Comparative Analysis Across Western European Countries, Canada, and Australia
Sep 9, 2025, 16:22 PM -
Single-Arm Trials and Reimbursement Decision Making in Europe: A Case Study in Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Activity of the French Economic and Public Health Evaluation Committee (CEESP): Retrospective of 10 Years of Economic Assessment on Health Products
Sep 9, 2025, 16:22 PM -
Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk
Sep 9, 2025, 16:22 PM -
Why TSD26 Matters: How Accurate Was Clinical Expert Opinion in Estimating Long-Term Outcomes?
Sep 9, 2025, 16:22 PM -
Deep Brain Stimulation: A Cost-Saving Treatment Option for Extreme Treatment-Refractory Obsessive-Compulsive Disorder in the UK?
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation
Sep 9, 2025, 16:22 PM -
Subsequent Treatments and NICE Appraisals for DLBCL: A Review of Committee Discussions
Sep 9, 2025, 16:22 PM -
The Relevance of the Use of TENS Devices in the Therapy of Poststroke Dysphagia
Sep 9, 2025, 16:22 PM -
Detection of a Potential Pericarditis Safety Signal Associated With Azithromycin: Evidence From FAERS Disproportionality Analysis
Sep 9, 2025, 16:22 PM -
Quo Vadis? The Emerging Role of the Medicines and Healthcare Products Regulatory Agency (MHRA) in an Evolving Regulatory Landscape
Sep 9, 2025, 16:22 PM -
Development of a Content-Valid Patient-Reported Outcome (PRO) Measure for Adults With Glycogen Storage Disease Type 1a (GSD1a): The GSD1a Symptom Diary-Adult Version
Sep 9, 2025, 16:22 PM -
Modeling Early vs. Late Intervention Strategies: The Case of Dupilumab in Children With Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Real-World Uptake of SGLT2i Usage in Patients With Chronic Kidney Disease or Heart Failure: A German Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis for an Efficacy Assessment of Avelumab Axitinib in the First-Line Treatment of International Metastatic RCC Database Consortium (IMDC) Favorable Risk Patients With Advanced Renal Cell Carcinoma (ARCC)
Sep 9, 2025, 16:22 PM -
The Use of Multiple Sleep Medications Is Highly Prevalent
Sep 9, 2025, 16:22 PM -
Addressing Payer Concerns: Opportunities for HEOR in Orphan Drug Development
Sep 9, 2025, 16:22 PM
